Imidazatriazoloquinazoline compounds and their use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544247, 544250, A61K 31505, C07D48714

Patent

active

052602982

ABSTRACT:
Imidazotriazoloquinazoline compounds having the general formula ##STR1## wherein A together with the .alpha.-marked carbon atom and the .beta.-marked nitrogen atom is one of the groups ##STR2## cyano or CO.sub.2 R.sup.5, wherein R.sup.5 is H, alkyl, cycloalkyl, trifluoromethyl or alkoxymethyl; and R.sup.2, R.sup.3 and R.sup.4 independently are H, hydroxy, halogen, CN, alkyl, alkenyl, alkynyl, trifluoromethyl, alkoxy, dialkylaminoalkoxy, aralkoxy, aryloxy which may be substituted, acyclic amino group, or NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 independently are H or alkyl.
The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, antipsychotics, antiemetics, or in improving the cognitive function of the brain of mammals, or as benzodiazepine antagonsists.

REFERENCES:
patent: 4774245 (1988-09-01), Watjen et al.
patent: 5100895 (1992-03-01), Hansen et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazatriazoloquinazoline compounds and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazatriazoloquinazoline compounds and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazatriazoloquinazoline compounds and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1142931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.